The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients

Memorias do Instituto Oswaldo Cruz

Volumn 109, Issue 1, 2014, Pages 29-37

  Silva, Bruna Daniella Souza ^a   Tannus Silva, Daniela Graner Schuwartz ^a   Rabahi, Marcelo Fouad ^a   Kipnis, Andre ^a   Junqueira Kipnis, Ana Paula ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Anti TNF ; Latent infected tuberculosis; Th cells

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; HSPX PROTEIN, MYCOBACTERIUM TUBERCULOSIS; INTERLEUKIN 6; MALATE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD; CELLULAR IMMUNITY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, BACTERIAL; ARTHRITIS, RHEUMATOID; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-6; LATENT TUBERCULOSIS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALATE SYNTHASE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047687471     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760140140     Document Type: Article

References (37)

1. Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordstrom DC, Blom M 2012. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS ONE 7: e30275.
2. Araújo-Filho JA, Vasconcelos ACJ, Sousa EM, Kipnis A, Junqueira-Kipnis AP 2008. Cellular responses to MPT-51, GlcB and ES-AT-6 among MDR-TB and active tuberculosis patients in Brazil. Tuberculosis 88: 474-481.
3. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman T B 2010. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis 201: 20-31.
4. Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappingers D, Wilkinson RJ, Young D 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
5. Boissier MC, Assier E, Falgarone G, Bessis N 2008. Shifting the imbalance from Th1/Th2 to Th17/Treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 75: 373-375.
6. Brennan FM, McInnes IB 2008. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118: 3537-3545.
7. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P 1999. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42: 963-970.
8. Chen J, Li J, Gao H, Wang C, Luo J, Lv Z, Li X 2012. Comprehensive evaluation of different T-helper cells subsets differentiation and function in rheumatoid arthritis. J Biomed Biotechnol 2012: ID 535361.
9. + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59.
10. Cope AP 2008. T cells in rheumatoid arthritis. Arthritis Res Ther 10: 1-10.
11. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG 2009. CE: IFN-g regulates the induction and expansion of IL-17 producing CD4 T cells during mycobacterial infection. J Immunol 177: 1416-1420.
12. Ellner JJ 2010. Immunoregulation in TB: observations and implications. Clin Transl Sci 3: 23-28.
13. + regulatory cells. Nat Immunol 4: 330-336.
14. Guyot-Revol V, John AI, Hackfort S, Hinks T, Lalvani A 2006. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
15. Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, Marcart F 2007. Regulatory T cells depress immune response to protective antigens in active tuberculosis. Am J Respir Crit Care Med 176: 409-416.
16. Jick SS, Lieberman ES, Rahman MU, Choi HK 2006. Glucocorticoid use, other associated factors and the risk of tuberculosis. Arthritis Reum 55: 19-26.
17. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
18. Matulis G, Juni P, Villiger PM, Gadola SD 2008. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigenspecific interferon gamma assay. Ann Rheum Dis 67: 84-90.
19. Mota LMH, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, Freitas MVC, Silva NA, Louzada-Júnior P, Giorgi RDN, Lima RAC, Pinheiro GRC 2012. Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatóide. Rev Bras Reumatol 52: 135-174.
20. Mus AM, Cornelissen F, Asmawidjaja PS, Hamburg JP, Boon L, Hendriks RW, Lubberts E 2010. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FOXP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis. Arthritis Rheum 62: 1043-1050.
21. Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Dominique Tripodi D 2013. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in health care workers. Expert Rev Anti Infect Ther 11: 37-48.
22. Okada M, Kita Y, Kanamaru N, Hashimoto S, Uchiyama Y, Mihara M, Inoue Y, Ohsugi Y, Kishimoto T, Sakatani M 2011. Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice. Clinical Dev Immunol 2011: e404929.
23. Rabahi MF, Junqueira-Kipnis AP, Dos Reis MC, Oelemann W, Conde MB 2007. Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis. BMC Infect Dis 7: 148-151.
24. Reis MC, Rabahi MF, Kipnis A, Junqueira-Kipnis AP 2009. Health care workers humoral immune response against GLcB, MPT51 and HSPX from Mycobacterium tuberculosis. Braz J Infect Dis 13: 417-421.
25. + T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 144: 25-34.
26. Roberts T, Beyers N, Aguirre A, Walzl G 2007. Immunosuppression during active tuberculosis is characterized by decreased interferon-γ production and CD25 expression with elevated forkhead box P3, transforming growth factor-β and interleukin-4 mRNA levels. J Infect Dis 195: 870-878.
27. Rueda CM, Marín ND, García LF, Rojas M 2010. Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis. Tuberculosis 90: 346-353.
28. Scott DL, Wolfe F, Huizinga TW 2010. Rheumatoid arthritis. Lancet 376: 1094-1108.
29. + T cells subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962-1970.
30. Tannus-Silva DS, Silva BDS, Torres PP, Santana PJJ, Junqueira-Kipnis AP, Rabahi MF 2012. Latent tuberculosis in rheumatoid arthritis: evaluating cellular response and high-resolution computed tomography. Arch Bronconeumol 48: 144-149.
31. Tavares RCO, Salgado J, Moreira VB, Ferreira MAS, Mello FCQ, Leung JAW Leung JAW, Singh M, Fonseca LS, Saad MHF 2006. Cell proliferation and interferon-γ response to recombinant MBP-3, NarL, MT-10.3 and 16kDa Mycobacterium tuberculosis antigens in Brazilian tuberculosis patients. Mem Inst Oswaldo Cruz 101: 857-861.
32. Torrado E, Cooper AM 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 21: 455-462.
33. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ 2008. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J Rheumatol 35: 1271-1276.
34. Wang W, Shao S, Jiao Z, Guo M, Xu H, Wang S 2012. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 4: 887-893.
35. WHO-World Health Organization 2003. Risk of TB infection among HCWs in the era of HIV and MDR-TB. Available from: http//who.int/tb/events/archive/icmeeting_oct07/02_pai.pdf.
36. WHO-World Health Organization 2011. Fact sheets in tuberculosis: Regional Office for the Western Pacific. Available from: http//wpro.who.int/media_centre/fact_sheets/fs_20090327.htm.
37. Zhang L, Li Y, Li Y, Qi L, Liu X, Yuan C, Hu N, Ma D, Li Z, Yang Q, Li W, Li J 2012. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS ONE 7: e31000.